Akizawa T - Search Results

1

Effect of Treating Hyperphosphatemia With Lanthanum Carbonate vs Calcium Carbonate on Cardiovascular Events in Patients With Chronic Kidney Disease Undergoing Hemodialysis: The LANDMARK Randomized Clinical Trial.

Ogata H, Fukagawa M, Hirakata H, Kagimura T, Fukushima M, Akizawa T; LANDMARK Investigators and Committees. Ogata H, et al. Among authors: akizawa t. JAMA. 2021 May 18;325(19):1946-1954. doi: 10.1001/jama.2021.4807. JAMA. 2021. PMID: 34003226 Free PMC article. Clinical Trial.

2

Clinical effects of L-threo-3,4-dihydroxyphenylserine on orthostatic hypotension in hemodialysis patients.

Akizawa T, Koshikawa S, Iida N, Marumo F, Akiba T, Kawaguchi Y, Imada A, Yamazaki C, Suzuki M, Tubakihara Y. Akizawa T, et al. Nephron. 2002 Apr;90(4):384-90. doi: 10.1159/000054725. Nephron. 2002. PMID: 11961396 Clinical Trial.

3

Effects of L-threo-3,4-dihydroxyphenylserine on orthostatic hypotension in hemodialysis patients.

Iida N, Koshikawa S, Akizawa T, Tsubakihara Y, Marumo F, Akiba T, Kawaguchi Y, Imada A, Yamazaki C, Suzuki M. Iida N, et al. Among authors: akizawa t. Am J Nephrol. 2002 Jul-Aug;22(4):338-46. doi: 10.1159/000065224. Am J Nephrol. 2002. PMID: 12169865 Clinical Trial.

4

Effects of 1,25-dihydroxy-22-oxavitamin D(3) on parathyroid gland function in haemodialysis patients with secondary hyperparathyroidism.

Kinugasa E, Akizawa T, Takahashi J, Nabeshima K, Ogata H, Nakayama F, Ideura T. Kinugasa E, et al. Among authors: akizawa t. Nephrol Dial Transplant. 2002;17 Suppl 10:20-7. doi: 10.1093/ndt/17.suppl_10.20. Nephrol Dial Transplant. 2002. PMID: 12386265 Clinical Trial.

5

Long-term effect of 1,25-dihydroxy-22-oxavitamin D(3) on secondary hyperparathyroidism in haemodialysis patients. One-year administration study.

Akizawa T, Suzuki M, Akiba T, Nishizawa Y, Ohashi Y, Ogata E, Slatopolsky E, Kurokawa K. Akizawa T, et al. Nephrol Dial Transplant. 2002;17 Suppl 10:28-36. doi: 10.1093/ndt/17.suppl_10.28. Nephrol Dial Transplant. 2002. PMID: 12386266 Clinical Trial.

6

New strategies for the treatment of secondary hyperparathyroidism.

Akizawa T, Shiizaki K, Hatamura I, Kamimura M, Mizobuchi M, Narukawa N, Sumikado S, Sakaguchi T, Negi S, Ogata H, Kinugasa E. Akizawa T, et al. Am J Kidney Dis. 2003 Mar;41(3 Suppl 1):S100-3. doi: 10.1053/ajkd.2003.50095. Am J Kidney Dis. 2003. PMID: 12612963 Review.

7

Guidelines for percutaneous ethanol injection therapy of the parathyroid glands in chronic dialysis patients.

Fukagawa M, Kitaoka M, Tominaga Y, Akizawa T, Kakuta T, Onoda N, Koiwa F, Yumita S, Kurokawa K; Japanese Society for Parathyroid Intervention. Fukagawa M, et al. Among authors: akizawa t. Nephrol Dial Transplant. 2003 Jun;18 Suppl 3:iii31-3. doi: 10.1093/ndt/gfg1008. Nephrol Dial Transplant. 2003. PMID: 12771296

8

Clinical analysis of renoprotective responding patients administrated with oral adsorbent in chronic renal failure secondary to chronic glomerulonephritis.

Sanaka T, Akizawa T, Koide K, Koshikawa S. Sanaka T, et al. Among authors: akizawa t. Ther Apher Dial. 2003 Apr;7(2):269-78. doi: 10.1046/j.1526-0968.2003.00024.x. Ther Apher Dial. 2003. PMID: 12918955

9

Management of secondary hyperparathyroidism of dialysis patients.

Akizawa T, Kamimura M, Mizobuchi M, Shiizaki K, Sumikado S, Sakaguchi T, Negi S, Ogata H, Kinugasa E. Akizawa T, et al. Nephrology (Carlton). 2003 Oct;8 Suppl:S53-7. doi: 10.1046/j.1440-1797.8.s.9.x. Nephrology (Carlton). 2003. PMID: 15012693 Review.

10

Extracorporeal albumin dialysis.

Abe T, Shono M, Kodama T, Kita Y, Fukagawa M, Akizawa T. Abe T, et al. Among authors: akizawa t. Ther Apher Dial. 2004 Jun;8(3):217-22. doi: 10.1111/j.1526-0968.2004.00148.x. Ther Apher Dial. 2004. PMID: 15154874

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

583 results

Search Page